Balanced news tone
News Sentiment
DOCS sentiment intelligence
Doximity Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
82/100 classification confidence.
directly relevant articles
high-authority source matches
+2.1% over one week, +2.6% over four weeks, trend inactive, and below fair value.
Doximity (NYSE: DOCS) president discloses 822 Class A shares
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Doximity Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Doximity, Inc. (NYSE: DOCS) is set to release its fourth-quarter earnings on Wednesday, May 13, with analysts expecting 28 cents per share and $143.91 million in revenue. Ahead of the announcement, several analysts from firms like B of A Securities, Keybanc, Evercore ISI Group, J
- Tone
- Negative 40/100
- Event
- Earnings
- Published
- 14 May 2026 14:39
- Source
- Sahm
Doximity Stock Falls on Q4 Earnings Miss, Revenues Beat, Margins Down
- Tone
- Negative 22/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- TradingView
Doximity (DOCS) interim PFO exercises options and sells 2,309 shares under 10b5-1 plan
Doximity's interim PFO and PAO, Siddharth Sitaram, engaged in routine equity transactions, exercising stock options for 5,000 Class B shares, which converted to Class A shares. Concurrently, he sold 2,309 Class A shares at $25.77 each through a pre-planned 10b5-1 "sell-to-cover"
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 May 2026 20:09
- Source
- Stock Titan
Doximity interim PFO Siddharth sells $59,502 of class A stock
Sitaram Siddharth, Interim Principal Financial Officer at Doximity, sold 2,309 shares of Class A Common Stock worth $59,502 on May 11, 2026, as part of a Rule 10b5-1 trading plan and to cover tax obligations. Simultaneously, he acquired 5,000 Class A shares through the conversion
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 May 2026 20:09
- Source
- Investing.com
Doximity Stock Dives On Q4 Earnings, Weak Outlook
- Tone
- Negative 34/100
- Event
- Guidance
- Published
- 13 May 2026 07:00
- Source
- Market source
Doximity Flags Pharma Ad Market Weakness
Doximity's shares fell after the company reported mixed Q4 results and issued soft annual guidance, citing weakness in the HCP Digital Pharma ad market. Despite increased engagement and AI tool adoption among prescribers, several analysts downgraded the stock and lowered price ta
- Tone
- Negative 14/100
- Event
- Earnings
- Published
- 12 May 2026 22:40
- Source
- Sahm
Precision Trading with Doximity Inc. Class A (DOCS) Risk Zones
This article provides a precision trading analysis for Doximity Inc. Class A (DOCS), highlighting strong near and mid-term sentiment despite a weak long-term outlook. It details specific institutional trading strategies (Position, Momentum Breakout, Risk Hedging) with entry zones
- Tone
- Negative 41/100
- Event
- Guidance
- Published
- 12 May 2026 15:40
- Source
- Stock Traders Daily
Doximity, Inc. Class A Common Stock (NY: DOCS)
This page provides a news compilation for Doximity, Inc. Class A Common Stock (NYSE: DOCS), featuring various headlines and brief descriptions from June 2023 back to May 2023. The articles cover topics such as Doximity's growth potential, financial performance, analyst ratings, n
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 11 May 2026 10:09
- Source
- FinancialContent
Doximity director Kira Scherer Wampler sells $234,540 of Class A stock
Doximity director Kira Scherer Wampler sold 9,000 shares of Class A Common Stock for $234,540 on May 7, 2026, following the exercise and conversion of stock options. This sale was conducted via a Rule 10b5-1 trading plan. The transaction occurred amidst a 52% decline in Doximity
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 May 2026 22:09
- Source
- Investing.com
Doximity Stock Down 40% in 2026: Is the Selloff Building a Multi-Year Entry Opportunity?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 May 2026 07:00
- Source
- TIKR.com
Is Doximity, Inc. (DOCS) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 May 2026 07:00
- Source
- Market source
Assessing Doximity (DOCS) Valuation After Recent Share Price Volatility
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Market source
Doximity (DOCS) Stock Dips While Market Gains: Key Facts
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 Apr 2026 07:00
- Source
- Market source
Is Doximity (DOCS) One of the Stocks Set to Explode in the Next 3 Years?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Apr 2026 07:00
- Source
- Market source
Has Doximity (DOCS) Become Attractive After Its Sharp Share Price Pullback?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Mar 2026 07:00
- Source
- Market source
SEC files settled insider trading charges against former Chief Revenue Officer of Doximity
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Mar 2026 07:00
- Source
- FX News Group
What Triggered Doximity's Recent Stock Plunge
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Feb 2026 09:39
- Source
- Kavout
Doximity, Inc.'s (NYSE:DOCS) Popularity With Investors Under Threat As Stock Sinks 27%
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Feb 2026 08:00
- Source
- simplywall.st
Doximity Stock Falls Despite Q3 Earnings & Revenues Beat Estimates
- Tone
- Negative 38/100
- Event
- Earnings
- Published
- 06 Feb 2026 08:00
- Source
- TradingView
Doximity, Inc. (DOCS) Stock Analysis: Healthcare Platform's Potential 68% Upside Sparks Investor Interest
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Feb 2026 08:00
- Source
- DirectorsTalk Interviews
At US$67.94, Is Doximity, Inc. (NYSE:DOCS) Worth Looking At Closely?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Sep 2025 07:00
- Source
- simplywall.st
We Think Doximity's (NYSE:DOCS) Profit Is Only A Baseline For What They Can Achieve
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 15 Aug 2025 07:00
- Source
- simplywall.st
Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Aug 2025 07:00
- Source
- CNBC